Agilent Technologies, Inc. $A Shares Acquired by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP lifted its holdings in Agilent Technologies, Inc. (NYSE:A) by 23.7% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,808,380 shares of the medical research company’s stock after buying an additional 346,428 shares during the quarter. Dimensional Fund Advisors LP’s holdings in Agilent Technologies were worth $232,018,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Brighton Jones LLC lifted its holdings in Agilent Technologies by 6.1% in the fourth quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company’s stock valued at $626,000 after acquiring an additional 270 shares during the period. Jones Financial Companies Lllp grew its position in Agilent Technologies by 15.9% during the first quarter. Jones Financial Companies Lllp now owns 5,610 shares of the medical research company’s stock worth $602,000 after buying an additional 769 shares during the period. Geneos Wealth Management Inc. increased its holdings in Agilent Technologies by 54.8% in the first quarter. Geneos Wealth Management Inc. now owns 599 shares of the medical research company’s stock valued at $70,000 after buying an additional 212 shares in the last quarter. Acadian Asset Management LLC lifted its position in shares of Agilent Technologies by 16.5% during the 1st quarter. Acadian Asset Management LLC now owns 5,352 shares of the medical research company’s stock valued at $625,000 after acquiring an additional 758 shares during the period. Finally, Sivia Capital Partners LLC purchased a new stake in shares of Agilent Technologies during the 2nd quarter worth approximately $273,000.

Agilent Technologies Stock Down 2.5%

Shares of NYSE:A opened at $115.11 on Friday. The company has a quick ratio of 1.59, a current ratio of 2.07 and a debt-to-equity ratio of 0.44. The company has a market capitalization of $32.53 billion, a P/E ratio of 25.41, a P/E/G ratio of 2.42 and a beta of 1.31. Agilent Technologies, Inc. has a 52-week low of $96.43 and a 52-week high of $160.27. The stock’s fifty day simple moving average is $132.65 and its 200-day simple moving average is $136.00.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, February 25th. The medical research company reported $1.36 EPS for the quarter, missing analysts’ consensus estimates of $1.37 by ($0.01). Agilent Technologies had a return on equity of 24.49% and a net margin of 18.26%.The company had revenue of $1.80 billion for the quarter, compared to analysts’ expectations of $1.81 billion. During the same quarter in the prior year, the business posted $1.31 EPS. The company’s revenue for the quarter was up 7.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. As a group, equities research analysts forecast that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 22nd. Shareholders of record on Tuesday, March 31st will be paid a $0.255 dividend. This represents a $1.02 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Tuesday, March 31st. Agilent Technologies’s dividend payout ratio (DPR) is presently 22.52%.

Wall Street Analyst Weigh In

A has been the subject of several research reports. JPMorgan Chase & Co. lifted their price objective on Agilent Technologies from $165.00 to $180.00 and gave the stock an “overweight” rating in a report on Tuesday, November 25th. UBS Group cut their price target on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research note on Thursday, February 26th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Agilent Technologies in a research report on Monday, December 29th. Barclays reduced their price target on shares of Agilent Technologies from $165.00 to $150.00 and set an “overweight” rating on the stock in a report on Thursday, February 26th. Finally, Evercore upgraded shares of Agilent Technologies from an “in-line” rating to an “outperform” rating and increased their price target for the company from $155.00 to $160.00 in a research report on Monday, January 5th. Two investment analysts have rated the stock with a Strong Buy rating, eleven have issued a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $161.20.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.